Use of glutamate antagonists for the treatment of cancer

Details Use of glutamate antagonists for the treatment of cancer Use of glutamate antagonists for the treatment of cancer

Filed on

2007-07-24

Date issued

2007-07-24

Examiner

Wax, Robert A. (Department: 1656)

Patent Class

Drug, bio-affecting and body treating compositions

SubClass

Designated organic active ingredient containing

SubSubClass

Peptide containing doai

Other Related Categories

C514S080000, C514S247000, C514S258100, C424S009100

Type

Reexamination Certificate

Status

active

Patent number

10912159

Description

ABSTRACT:
Disclosed are methods for treating cancer by administering an inhibitor of the interaction of glutamate with the KA receptor complex.

REFERENCES:
patent: 5958930 (1999-09-01), Gangjee
patent: 6046180 (2000-04-01), Jackson et al.
Fletcher, E. and Lodge, D., Pharm. Ther. vol. 70, No. 1, pp. 65-89, 1996.
Xue, D. et al. (ABSTRACT) (J. Cereb Blood Flow Metab. 1994).
Turski, L. et al. PNAS 95: 10960-10965 (1998).
Browne SE and McCulloch J (ABSTRACT) (Brain Res. 1994).
Elting, J-W. et al. Stroke 33: 2813-2818 (2002).
Paternain et al. Neuron 14: 185-189 (1995).

Affiliated with

Also associated with

Rating

Use of glutamate antagonists for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of glutamate antagonists for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of glutamate antagonists for the treatment of cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3806956